Skip to content

Evaluation of State and Shade of White Spot Lesions After Using Different Remineralizing Agents (An in Vivo Study)

Evaluation of State and Shade of White Spot Lesions After Using Different Remineralizing Agents (An in Vivo Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04671134
Enrollment
20
Registered
2020-12-17
Start date
2017-06-01
Completion date
2019-06-01
Last updated
2020-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

White Spot Lesion

Brief summary

The aim of the study is to evaluate the effect of Biomimetic remineralizing agent and resin modified glass ionomer varnish on color shade and state of white spot lesions immediately, after 3 months, and after 6 months. (An in vivo study).

Interventions

OTHERBiomimetic remineralizing agent

Self-assempling peptide

Resin Modified Glass Ionomer Varnish

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients included in this clinical trial were less than 30 years old. 2. Patients with good general health. 3. Patients who will agree to the consent and will commit to follow-up period. 4. Fully erupted anterior teeth with no cavitated lesions.

Exclusion criteria

1. Patients with any systemic disease that may affect normal healing. 2. Patient with bad oral hygiene. 3. Tetracycline or florosis staining. 4. Patients who could/would not participate in all times of follow-up. 5. Untreated periodontal disease was not allowed. 6. Active caries or defective Restorations in 6 anterior teeth. 7. Bleaching history 8. Patients participating in more than 1 dental study. 9. Patient received fluoride varnish before.

Design outcomes

Primary

MeasureTime frameDescription
state of lesions6 months.Digital scores

Secondary

MeasureTime frameDescription
shade of lesions6 monthsDigital scores

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026